CBAY - Cymabay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q1 2021 Results - Earnings Call Transcript
Cymabay Therapeutics, Inc. (CBAY) Q1 2021 Earnings Conference Call May 13, 2021, 16:30 ET Company Participants Daniel Menold - VP, Finance Sujal Shah - President, CEO & Director Charles McWherter - SVP & Chief Scientific Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler & Co. Timur Ivannikov - Raymond James & Associates Patrick Dolezal - LifeSci Capital Matthew Hershenhorn - Oppenheimer Antonio Arce - H.C. Wainwright & Co. Alethia Young - Cantor Fitzgerald Benjamin Porter - Stifel, Nicolaus & Company Presentation Operator Good day, ladies and gentlemen, and welcome to CymaBay's First Quarter 2021 Financial Results and Business Update Conference call. [Operator Instructions]. Please be advised that this call will be recorded at the company's request. It is also being webcast live on the Investor section of CymaBay's website at www.cymabay.com. Now I would like to turn the call over to Mr. Dan Menold, Vice President of Financial at
For further details see:
Cymabay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q1 2021 Results - Earnings Call Transcript